“Anti-aging” UBX IPOs 5.75M* shares @$17.00: https://globenewswire.com/news-release/2018/05/02/1495498/0/en/UNITY-Biotechnology-Inc-Announces-Pricing-of-Initial-Public-Offering-of-Common-Stock.html UNITY Biotechnology is developing therapeutics to extend human healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related afflictions, such as osteoarthritis, eye diseases and pulmonary diseases.The company is located in Brisbane, CA (just south of San Frnacisco). *Assuming exercise of underwriter’s option.